273 related articles for article (PubMed ID: 16520108)
1. Stomach cancer.
Magnusson J
Curr Surg; 2006; 63(2):96-100; quiz 100-1. PubMed ID: 16520108
[No Abstract] [Full Text] [Related]
2. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
Zhang XH; Wang QZ
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
[No Abstract] [Full Text] [Related]
3. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
4. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
5. Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia.
Oblak I; Velenik V; Anderluh F; Strojan P
Eur J Surg Oncol; 2007 Oct; 33(8):982-7. PubMed ID: 17258881
[TBL] [Abstract][Full Text] [Related]
6. Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction and proximal gastric cancers: a comparison of normal tissue radiation doses.
Tillman GF; Pawlicki T; Koong AC; Goodman KA
Dis Esophagus; 2008; 21(5):437-44. PubMed ID: 19125798
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of gastric cancer.
Kranenbarg EK; van de Velde CJ
Ann Chir Gynaecol; 2000; 89(3):199-206. PubMed ID: 11079788
[No Abstract] [Full Text] [Related]
8. Adjuvant therapy in gastric cancer: can we prevent recurrences?
Meyerhardt JA; Fuchs CS
Oncology (Williston Park); 2003 May; 17(5):714-21, 728; discussion 728-9, 732-3. PubMed ID: 12800796
[TBL] [Abstract][Full Text] [Related]
9. D-dimer--can it be a marker for malignant gastric lesions?
Aliustaoglu M; Yumuk PF; Gumus M; Ekenel M; Bolukbas F; Bolukbas C; Mutlu N; Basaran G; Avsar E; Turhal NS
Acta Oncol; 2004; 43(8):770-1. PubMed ID: 15764225
[No Abstract] [Full Text] [Related]
10. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?
Badgwell B; Cormier JN; Krishnan S; Yao J; Staerkel GA; Lupo PJ; Pisters PW; Feig B; Mansfield P
Ann Surg Oncol; 2008 Oct; 15(10):2684-91. PubMed ID: 18649106
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
12. [Value of postoperative radiochemotherapy with 5-fluorouracil plus leucovorin in stage IB-IV M0 stomach carcinoma].
Hehr T; Adamek HE
Strahlenther Onkol; 2002 Mar; 178(3):164-6. PubMed ID: 11962195
[No Abstract] [Full Text] [Related]
13. Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy.
Grau JJ; Caballero M; Monzó M; Muñoz-García C; Domingo-Domenech J; Navarro A; Conill C; Campayo M; Bombí JA
J Surg Oncol; 2008 Aug; 98(2):130-4. PubMed ID: 18537153
[TBL] [Abstract][Full Text] [Related]
14. [Follow-up in stomach carcinoma].
Böhm B; Osswald J; Stock W
Leber Magen Darm; 1991 Mar; 21(2):68, 71-4. PubMed ID: 1645429
[TBL] [Abstract][Full Text] [Related]
15. Current treatment of gastric cancer: is adjuvant therapy of benefit?
Lin JW; Leach SD
Adv Surg; 2003; 37():95-121. PubMed ID: 12953629
[No Abstract] [Full Text] [Related]
16. [Gastric neoplasm, multidisciplinary management].
Bohanes Pi; Roth AD; Huber O; Aapro MS; Plan PA
Rev Med Suisse; 2009 Aug; 5(212):1569-75. PubMed ID: 19728453
[No Abstract] [Full Text] [Related]
17. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
[TBL] [Abstract][Full Text] [Related]
18. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
20. Current Management of Locally Advanced Junction Esophagogastric Adenocarcinoma.
Birla R; Hoara P; Caragui A; Cristian M; Constantinoiu S
Chirurgia (Bucur); 2018; 113(1):38-45. PubMed ID: 29509530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
